114 related articles for article (PubMed ID: 1385534)
1. Preparative-scale purification and characterization of MHC class II monomers.
Passmore D; Kopa D; Nag B
J Immunol Methods; 1992 Nov; 155(2):193-200. PubMed ID: 1385534
[TBL] [Abstract][Full Text] [Related]
2. Refolding and reconstitution of functionally active complexes of human leukocyte antigen DR2 and myelin basic protein peptide from recombinant alpha and beta polypeptide chains.
Arimilli S; Cardoso C; Mukku P; Baichwal V; Nag B
J Biol Chem; 1995 Jan; 270(2):971-7. PubMed ID: 7529765
[TBL] [Abstract][Full Text] [Related]
3. Purified beta-chain of MHC class II binds to CD4 molecules on transfected HeLa cells.
Nag B; Wada HG; Passmore D; Clark BR; Sharma SD; McConnell HM
J Immunol; 1993 Feb; 150(4):1358-64. PubMed ID: 8432982
[TBL] [Abstract][Full Text] [Related]
4. pH dependent binding of high and low affinity myelin basic protein peptides to purified HLA-DR2.
Mukku PV; Passmore D; Phan D; Nag B
Mol Immunol; 1995 Jun; 32(8):555-64. PubMed ID: 7541890
[TBL] [Abstract][Full Text] [Related]
5. N-linked oligosaccharides of murine major histocompatibility complex class II molecule. Role in antigenic peptide binding, T cell recognition, and clonal nonresponsiveness.
Nag B; Passmore D; Kendrick T; Bhayani H; Sharma SD
J Biol Chem; 1992 Nov; 267(31):22624-9. PubMed ID: 1385402
[TBL] [Abstract][Full Text] [Related]
6. Antigenic peptide binding to MHC class II molecules at increased peptide concentrations.
Nag B; Mukku PV; Arimilli S; Phan D; Deshpande SV; Winkelhake JL
Mol Immunol; 1994 Oct; 31(15):1161-8. PubMed ID: 7523870
[TBL] [Abstract][Full Text] [Related]
7. Functionally active recombinant alpha and beta chain-peptide complexes of human major histocompatibility class II molecules.
Nag B; Arimilli S; Mukku PV; Astafieva I
J Biol Chem; 1996 Apr; 271(17):10413-8. PubMed ID: 8626615
[TBL] [Abstract][Full Text] [Related]
8. Separation of complexes of major histocompatibility class II molecules and known antigenic peptide by metal chelate affinity chromatography.
Nag B; Mukku PV; Arimilli S; Kendrick T; Deshpande SV; Sharma SD
J Immunol Methods; 1994 Mar; 169(2):273-85. PubMed ID: 7510762
[TBL] [Abstract][Full Text] [Related]
9. Intramolecular charge heterogeneity in purified major histocompatibility class II alpha and beta polypeptide chains.
Nag B; Arimilli S; Koukis B; Rhodes E; Baichwal V; Sharma SD
J Biol Chem; 1994 Apr; 269(13):10061-70. PubMed ID: 8144505
[TBL] [Abstract][Full Text] [Related]
10. The role of N-linked oligosaccharides of MHC class II antigens in T cell stimulation.
Nag B; Wada HG; Arimilli S; Fok K; Passmore D; Sharma SD; McConnell HM
J Immunol Methods; 1994 Jun; 172(1):95-104. PubMed ID: 7515935
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of T cells by antigenic peptide complexed with isolated chains of major histocompatibility complex class II molecules.
Nag B; Wada HG; Deshpande SV; Passmore D; Kendrick T; Sharma SD; Clark BR; McConnell HM
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1604-8. PubMed ID: 7679510
[TBL] [Abstract][Full Text] [Related]
12. Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes.
Wucherpfennig KW; Hafler DA; Strominger JL
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8896-900. PubMed ID: 7568039
[TBL] [Abstract][Full Text] [Related]
13. Peptide binding inhibits aggregation of soluble MHC class II in solution.
Arimilli S; Astafieva I; Mukku PV; Cardoso C; Deshpande S; Nag B
IUBMB Life; 1999 Nov; 48(5):483-91. PubMed ID: 10637763
[TBL] [Abstract][Full Text] [Related]
14. Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions.
Godkin AJ; Smith KJ; Willis A; Tejada-Simon MV; Zhang J; Elliott T; Hill AV
J Immunol; 2001 Jun; 166(11):6720-7. PubMed ID: 11359828
[TBL] [Abstract][Full Text] [Related]
15. High affinity for class II molecules as a necessary but not sufficient characteristic of encephalitogenic determinants.
Wall M; Southwood S; Sidney J; Oseroff C; del Guericio MF; Lamont AG; Colón SM; Arrhenius T; Gaeta FC; Sette A
Int Immunol; 1992 Jul; 4(7):773-7. PubMed ID: 1379827
[TBL] [Abstract][Full Text] [Related]
16. Functional consequences of the binding of MHC class II-derived peptides to MHC class II.
Feili-Hariri M; Kao H; Mietzner TA; Morel PA
Int Immunol; 1996 Dec; 8(12):1857-65. PubMed ID: 8982770
[TBL] [Abstract][Full Text] [Related]
17. Antigen-specific apoptosis in immortalized T cells by soluble MHC class II-peptide complexes.
Arimilli S; Mumm JB; Nag B
Immunol Cell Biol; 1996 Feb; 74(1):96-104. PubMed ID: 8934660
[TBL] [Abstract][Full Text] [Related]
18. In vivo biotinylation of the major histocompatibility complex (MHC) class II/peptide complex by coexpression of BirA enzyme for the generation of MHC class II/tetramers.
Yang J; Jaramillo A; Shi R; Kwok WW; Mohanakumar T
Hum Immunol; 2004 Jul; 65(7):692-9. PubMed ID: 15301857
[TBL] [Abstract][Full Text] [Related]
19. Expression of recombinant HLA-DR2 molecules. Replacement of the hydrophobic transmembrane region by a leucine zipper dimerization motif allows the assembly and secretion of soluble DR alpha beta heterodimers.
Kalandadze A; Galleno M; Foncerrada L; Strominger JL; Wucherpfennig KW
J Biol Chem; 1996 Aug; 271(33):20156-62. PubMed ID: 8702739
[TBL] [Abstract][Full Text] [Related]
20. Poor loading of major histocompatibility complex class II molecules with endogenously synthesized short peptides in the absence of invariant chain.
Busch R; Vturina IY; Drexler J; Momburg F; Hämmerling GJ
Eur J Immunol; 1995 Jan; 25(1):48-53. PubMed ID: 7843252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
